The price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week. Remdesivir is at the forefront of the fight against COVID-19 after the anti-viral treatment helped shorten hospital recovery times in a clinical
- Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.
Remdesivir is at the forefront of the fight against COVID-19 after the anti-viral treatment helped shorten hospital recovery times in a clinical trial. It has been approved for emergency use in some patients in the United States.The remdesivir price for U.S. private insurance companies will be $520 per vial, Gilead said, which equates to $3,120 per patient for a treatment course of six vials.Analysts at Royal Bank of Canada said they saw revenue potential of $2.
HHS has secured more than 500,000 treatment courses of the drug for U.S. hospitals through September, the agency said on Monday. Remdesivir's price has been a topic of intense debate since U.S. regulators approved its emergency use in some COVID-19 patients in May. Experts have said Gilead would need to avoid appearing to take advantage of a health crisis for profits.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead sets price for Covid-19 treatment as HHS secures dosesThat puts the price of a five-day treatment course at $2,340 per patient for people enrolled in federal health programs.
Read more »
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient.
Read more »
Women 'on precipice' in developing countries amid COVID-19The COVID-19 pandemic means that millions of women in Africa and other developing regions could lose years of success in contributing to household incomes, asserting their independence and expanding financial inclusion.
Read more »
How U.S. Prisons Became Ground Zero for Covid-19Tight quarters, strained hygiene practices and guards moving to and from their community put prisons at risk of becoming coronavirus hotbeds.
Read more »
How Boeing’s Confident Travel Initiative Works To Minimize Covid-19 SpreadHere's how Boeing’s confident travel initiative works to minimize the Covid-19 spread:
Read more »
Why are similar countries experiencing COVID-19 so differently?The US has new coronavirus infection rates that look more like countries that spend much less on health care, particularly Brazil and Russia. - MeetThePress
Read more »